| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |